Funding
Accelerator investment · Healthtech

Sarvas Health secures £60,000 from BGV for chronic disease decision support

Bethnal Green Ventures backs Sarvas Health through its Autumn 2025 Tech for Good programme, combining equity investment with six weeks of founder support.

By RoundOS Funding desk

Sarvas Health secured £60,000 from Bethnal Green Ventures through its Autumn 2025 Tech for Good programme. The investor announced the company’s addition to its portfolio on September 8, 2025. The programme provides the investment in return for a 7% equity stake, alongside six weeks of founder support and mentorship.

Sarvas Health is developing an AI model to support the prevention and earlier identification of chronic diseases. Its work focuses on primary care and community settings, where signals of disease can appear before a hospital diagnosis.

Funding history

Accelerator investment · This round£60K

Sources

  1. Meet our Autumn 2025 cohortbethnalgreenventures.com · Sep 8, 2025
  2. Apply for the BGV Autumn 2025 Tech for Good Programmebethnalgreenventures.com · May 1, 2025
  3. Sarvas Healthsarvas.co.uk

Similar rounds

All Healthtech rounds →
JawBuddy

JawBuddy develops guided jaw-exercise software for people managing jaw tension, teeth grinding and related discomfort.

€818KPre-seed · Nov 4, 2026
Biograil

Biograil develops oral capsules designed to deliver biologic medicines through the stomach wall, offering an alternative route for treatments given by injection.

€20MFinancing round · Nov 4, 2026
Active Intelligence Technologies

Active Intelligence Technologies develops implantable brain-computer interfaces to help patients regain communication, movement and sensory function.

CN¥464MAngel+ · Nov 4, 2026
Transtreams Technology

Transtreams Technology develops video-processing chips and AI hardware for cloud platforms and edge-computing applications.

CN¥1BSeries B · Nov 4, 2026

Related